Sinew Pharma Statistics
Total Valuation
Sinew Pharma has a market cap or net worth of TWD 4.77 billion. The enterprise value is 3.57 billion.
Market Cap | 4.77B |
Enterprise Value | 3.57B |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Sinew Pharma has 71.33 million shares outstanding. The number of shares has increased by 1.87% in one year.
Shares Outstanding | 71.33M |
Shares Change (YoY) | +1.87% |
Shares Change (QoQ) | +0.59% |
Owned by Insiders (%) | 5.06% |
Owned by Institutions (%) | 0.03% |
Float | 58.45M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 3.78 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -19.98 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -27.84 |
Financial Position
The company has a current ratio of 44.44, with a Debt / Equity ratio of 0.48.
Current Ratio | 44.44 |
Quick Ratio | 44.41 |
Debt / Equity | 0.48 |
Debt / EBITDA | n/a |
Debt / FCF | -0.05 |
Interest Coverage | -317.54 |
Financial Efficiency
Return on equity (ROE) is -13.35% and return on invested capital (ROIC) is -9.14%.
Return on Equity (ROE) | -13.35% |
Return on Assets (ROA) | -9.00% |
Return on Capital (ROIC) | -9.14% |
Revenue Per Employee | n/a |
Profits Per Employee | -3.50M |
Employee Count | 52 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.47% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -7.47% |
50-Day Moving Average | 70.04 |
200-Day Moving Average | 66.79 |
Relative Strength Index (RSI) | 44.09 |
Average Volume (20 Days) | 43,726 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -196.87M |
Pretax Income | -178.48M |
Net Income | -178.48M |
EBITDA | -173.07M |
EBIT | -196.87M |
Earnings Per Share (EPS) | -2.52 |
Balance Sheet
The company has 1.21 billion in cash and 6.10 million in debt, giving a net cash position of 1.21 billion or 16.91 per share.
Cash & Cash Equivalents | 1.21B |
Total Debt | 6.10M |
Net Cash | 1.21B |
Net Cash Per Share | 16.91 |
Equity (Book Value) | 1.26B |
Book Value Per Share | 17.72 |
Working Capital | 1.21B |
Cash Flow
In the last 12 months, operating cash flow was -123.20 million and capital expenditures -4.88 million, giving a free cash flow of -128.08 million.
Operating Cash Flow | -123.20M |
Capital Expenditures | -4.88M |
Free Cash Flow | -128.08M |
FCF Per Share | -1.80 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Sinew Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.87% |
Shareholder Yield | -1.87% |
Earnings Yield | -3.76% |
FCF Yield | -2.68% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |